SSA
DXCM icon

Schonfeld Strategic Advisors’s DexCom DXCM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,000
Closed -$1.86M – 2143
2023
Q4 		$1.86M Buy
+15,000
New +$1.53M 0.01% 821

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schonfeld Strategic Advisors's DXCM Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its DexCom (DXCM) stake by 61% in Q1 2026, selling an estimated $16.5M and leaving 152,930 shares worth $9.6M. The position accounts for 0.07% of the portfolio, ranked #308.

Schonfeld Strategic Advisors first reported a position in DXCM in Q4 2016 and has held it in 37 quarters since. The position peaked at $28.3M in Q3 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Schonfeld Strategic Advisors held 152,930 shares of DexCom worth $9.6M as of Q1 2026.
  • Schonfeld Strategic Advisors sold 237,529 DexCom shares in Q1 2026, an estimated $16.5M.
  • DexCom made up 0.07% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #308 holding.
  • Schonfeld Strategic Advisors first reported a position in DexCom in Q4 2016 and has held it in 37 quarters since.
  • Schonfeld Strategic Advisors's DexCom position peaked at $28.3M in Q3 2023.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.